{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:08:46Z","timestamp":1790784526442,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26710010"],"award-info":[{"award-number":["26710010"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H03523"],"award-info":[{"award-number":["18H03523"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1ZIABC011513"],"award-info":[{"award-number":["1ZIABC011513"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10120-019-00988-y","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T19:02:27Z","timestamp":1563044547000},"page":"82-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT"],"prefix":"10.1007","volume":"23","author":[{"given":"Takashi","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-5134","authenticated-orcid":false,"given":"Makoto","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,13]]},"reference":[{"key":"988_CR1","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","volume":"24","author":"AD Wagner","year":"2006","unstructured":"Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24:2903\u20139.","journal-title":"J Clin Oncol."},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"C Gravalos","year":"2008","unstructured":"Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19:1523\u20139.","journal-title":"Ann Oncol."},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","volume":"52","author":"M Hofmann","year":"2008","unstructured":"Hofmann M, Stoss O, Shi D, B\u00fcttner R, van de Vijver M, Kim W, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008;52:797\u2013805.","journal-title":"Histopathology"},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/annonc\/mdi064","volume":"16","author":"M Tanner","year":"2005","unstructured":"Tanner M, Hollm\u00e9n M, Junttila TT, Kapanen AI, Tommola S, Soini Y, et al. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol. 2005;16:273\u20138.","journal-title":"Ann Oncol."},{"key":"988_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet"},{"key":"988_CR6","first-page":"597","volume":"10","author":"Y Krupitskaya","year":"2009","unstructured":"Krupitskaya Y, Wakelee HA. Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer. Curr Opin Investig Drugs. 2009;10:597\u2013605.","journal-title":"Curr Opin Investig Drugs."},{"key":"988_CR7","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","volume":"96","author":"A Aguayo","year":"2000","unstructured":"Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 2000;96:2240\u20135.","journal-title":"Blood"},{"key":"988_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249\u201357.","journal-title":"Nature"},{"key":"988_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s001099900019","volume":"77","author":"N Ferrara","year":"1999","unstructured":"Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl). 1999;77:527\u201343.","journal-title":"J Mol Med (Berl)."},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1359-6101(96)00027-5","volume":"7","author":"M Klagsbrun","year":"1996","unstructured":"Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 1996;7:259\u201370.","journal-title":"Cytokine Growth Factor Rev."},{"key":"988_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","volume":"13","author":"G Neufeld","year":"1999","unstructured":"Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9\u201322.","journal-title":"FASEB J."},{"key":"988_CR12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0959-8049(02)00013-8","volume":"38","author":"YD Jung","year":"2002","unstructured":"Jung YD, Mansfield PF, Akagi M, Takeda A, Liu W, Bucana CD, et al. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model. Eur J Cancer. 2002;38:1133\u201340.","journal-title":"Eur J Cancer."},{"key":"988_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","volume":"383","author":"CS Fuchs","year":"2014","unstructured":"Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383:31\u20139.","journal-title":"Lancet"},{"key":"988_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15:1224\u2013355.","journal-title":"Lancet Oncol."},{"key":"988_CR15","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/nm.2554","volume":"17","author":"M Mitsunaga","year":"2011","unstructured":"Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011;17:1685\u201391.","journal-title":"Nat Med."},{"key":"988_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12885-016-2072-0","volume":"16","author":"K Ito","year":"2016","unstructured":"Ito K, Mitsunaga M, Arihiro S, Saruta M, Matsuoka M, Kobayashi H, et al. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms. BMC Cancer. 2016;16:37.","journal-title":"BMC Cancer."},{"key":"988_CR17","doi-asserted-by":"publisher","first-page":"14143","DOI":"10.18632\/oncotarget.7490","volume":"7","author":"K Ito","year":"2016","unstructured":"Ito K, Mitsunaga M, Nishimura T, Kobayashi H, Tajiri H. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging. Oncotarget. 2016;7:14143\u2013522.","journal-title":"Oncotarget."},{"key":"988_CR18","doi-asserted-by":"publisher","first-page":"e113276","DOI":"10.1371\/journal.pone.0113276","volume":"9","author":"K Sato","year":"2014","unstructured":"Sato K, Choyke PL, Kobayashi H. Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model. PLoS One. 2014;9:e113276.","journal-title":"PLoS One"},{"key":"988_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1158\/1535-7163.MCT-14-0658","volume":"14","author":"K Sato","year":"2015","unstructured":"Sato K, Hanaoka H, Watanabe R, Nakajima T, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Mol Cancer Ther. 2015;14:141\u201350.","journal-title":"Mol Cancer Ther."},{"key":"988_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7150\/thno.11559","volume":"5","author":"K Sato","year":"2015","unstructured":"Sato K, Nagaya T, Choyke PL, Kobayashi H. Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience. Theranostics. 2015;5:698\u2013709.","journal-title":"Theranostics."},{"key":"988_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10549-015-3265-y","volume":"149","author":"K Shimoyama","year":"2015","unstructured":"Shimoyama K, Kagawa S, Ishida M, Watanabe S, Noma K, Takehara K, et al. Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells. Breast Cancer Res Treat. 2015;149:597\u2013605.","journal-title":"Breast Cancer Res Treat"},{"key":"988_CR22","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1021\/acs.bioconjchem.7b00144","volume":"28","author":"K Ito","year":"2017","unstructured":"Ito K, Mitsunaga M, Nishimura T, Saruta M, Iwamoto T, Kobayashi H, et al. Near-infrared photochemoimmunotherapy by photoactivatable bifunctional antibody-drug conjugates targeting human epidermal growth factor receptor 2 positive cancer. Bioconjug Chem. 2017;28:1458\u201369.","journal-title":"Bioconjug Chem."},{"key":"988_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/his.12348","volume":"64","author":"M Ishida","year":"2014","unstructured":"Ishida M, Sekine S, Taniguchi H, Fukagawa T, Katai H, Kushima R. Consistent absence of HER2 expression, regardless of HER2 amplification status, in neuroendocrine carcinomas of the stomach. Histopathology. 2014;64:1027\u201331.","journal-title":"Histopathology"},{"key":"988_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/modpathol.2011.198","volume":"25","author":"J R\u00fcschoff","year":"2012","unstructured":"R\u00fcschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, et al. HER2 testing in gastric cancer: a practical approach. Mod Pathol. 2012;25:637\u201350.","journal-title":"Mod Pathol."},{"key":"988_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989;24:148\u201354.","journal-title":"Cancer Chemother Pharmacol."},{"key":"988_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1200\/JCO.1995.13.2.477","volume":"13","author":"K Maeda","year":"1995","unstructured":"Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol. 1995;13:477\u201381.","journal-title":"J Clin Oncol."},{"key":"988_CR27","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1021\/nn305011p","volume":"7","author":"K Sano","year":"2013","unstructured":"Sano K, Nakajima T, Choyke PL, Kobayashi H. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. ACS Nano. 2013;7:717\u201324.","journal-title":"ACS Nano"},{"key":"988_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.04.003","volume":"232","author":"T Nagaya","year":"2016","unstructured":"Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Kobayashi H. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT). J Control Release. 2016;232:1\u20138.","journal-title":"J Control Release."},{"key":"988_CR29","doi-asserted-by":"publisher","first-page":"98004","DOI":"10.1117\/1.JBO.19.9.098004","volume":"19","author":"CP Liang","year":"2014","unstructured":"Liang CP, Nakajima T, Watanabe R, Sato K, Choyke PL, Chen Y, et al. Real-time monitoring of hemodynamic changes in tumor vessels during photoimmunotherapy using optical coherence tomography. J Biomed Opt. 2014;19:98004.","journal-title":"J Biomed Opt."},{"key":"988_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1021\/bc200648m","volume":"23","author":"M Mitsunaga","year":"2012","unstructured":"Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjug Chem. 2012;23:604\u20139.","journal-title":"Bioconjug Chem"},{"key":"988_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/1471-2407-14-389","volume":"14","author":"T Nakajima","year":"2014","unstructured":"Nakajima T, Sato K, Hanaoka H, Watanabe R, Harada T, Choyke PL, et al. The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity. BMC Cancer. 2014;14:389.","journal-title":"BMC Cancer."},{"key":"988_CR32","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.18632\/oncotarget.14425","volume":"8","author":"M Ogawa","year":"2017","unstructured":"Ogawa M, Tomita Y, Nakamura Y, Lee MJ, Lee S, Tomita S, et al. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget. 2017;8:10425\u201336.","journal-title":"Oncotarget."},{"key":"988_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2326-6066.CIR-18-0546","volume":"7","author":"T Nagaya","year":"2019","unstructured":"Nagaya T, Friedman J, Maruoka Y, Ogata F, Okuyama S, Clavijo PE, et al. Host immunity following near-infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors. Cancer Immunol Res. 2019;7:401\u201313.","journal-title":"Cancer Immunol Res."},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-09-2797","volume":"16","author":"NR Smith","year":"2010","unstructured":"Smith NR, Baker D, James NH, Ratcliffe K, Jenkins M, Ashton SE, et al. Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res. 2010;16:3548\u201361.","journal-title":"Clin Cancer Res."}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-019-00988-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:02:14Z","timestamp":1594598534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-019-00988-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s10120-019-00988-y","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,13]]},"assertion":[{"value":"5 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}